Mass tort lead generation is the process of acquiring potential claimants for a specific injury or product litigation at scale, then screening them down to signed, qualified cases. The economics are unusual: a single signed retainer in an active tort can be worth tens of thousands of dollars in eventual fees, and the firm holding the largest qualified docket often sits in the strongest settlement position. That is why acquisition is competitive, and why the number that matters is not cost per lead but cost per signed and qualified case.

Last reviewed: August 2026

This guide covers the channels that produce claimant volume, how intake teams qualify raw leads into signable cases, what an acquired case actually costs, and the two compliance regimes (ABA advertising rules and the TCPA) that decide whether a campaign is defensible. For firms building a broader acquisition engine, see our overview of marketing for law firms.

What is mass tort lead generation?

Mass tort lead generation identifies people harmed by the same product, drug, or exposure (think a specific medical device, pharmaceutical, or contamination event) and converts them into screened claimants for a plaintiff firm. Unlike single-case personal injury intake, it runs at volume against one litigation at a time, and it lives or dies on qualification: an unqualified lead is not a discounted case, it is a cost.

The work splits into two halves. The front half is media: buying attention from the exposed population across paid social, search, and referral channels. The back half is intake: contacting each responder fast, confirming product exposure and injury criteria, checking the statute of limitations, and gathering the records that make a case signable. Firms that treat only the front half as marketing tend to overpay for cases that never survive review.

Which channels generate qualified claimant leads?

The channels that produce mass tort claimants are paid social (primarily Facebook and Instagram), paid search on tort-specific keywords, Google Local Services Ads, organic SEO and content, and purchased leads from specialist generators. Most mature campaigns run several at once because each channel reaches the exposed population at a different moment of intent.

Paid social wins on volume and targeting breadth because the demographic exposed to many torts (older consumers, specific medical histories) is reachable on Facebook and Instagram. Paid search wins on intent: someone typing “hernia mesh settlement” or “Camp Lejeune claim” is already looking. The table below compares the main options.

For the social side specifically, the creative and targeting mechanics differ enough from other verticals that we cover them separately in Facebook ads for lawyers and in our broader guide to social media lead generation.

How does intake and qualification work?

Intake turns a raw responder into a signed, qualified case through a fixed sequence: fast contact, eligibility screening, records collection, retainer, and quality review. Speed at the first step and discipline at the screening step are what separate a profitable docket from a pile of unusable leads. Most firms lose the majority of raw leads here, by design.

A workable qualification process usually runs in this order:

1. Rapid first contact. Reach the responder within minutes, not hours, while intent is warm. Speed-to-lead is often the single largest lever on conversion.
2. Eligibility screening. Confirm product or exposure, approximate injury type and timing, and that the claim falls inside the statute of limitations for the relevant jurisdiction.
3. Criteria match. Check the specific inclusion criteria the litigation requires (for example a documented diagnosis, a date range of use, or a qualifying dosage).
4. Records and documentation. Collect medical records, proof of purchase or exposure, and identity verification that make the case provable, not just plausible.
5. Retainer execution. Send and secure a signed contingency agreement, ideally through a tracked e-signature flow.
6. Quality assurance review. Re-screen signed cases before they enter the docket or are delivered to co-counsel, so weak files are caught early.

Two roles decide throughput: intake specialists who screen and a QA layer that audits their work. When a firm buys leads, the vendor may run steps one and two, but the firm still owns the risk if those steps were done without proper consent or accurate screening.

What does it cost to acquire a signed case?

Cost per acquired case, not cost per lead, is the metric that governs mass tort profitability. Cost per lead in 2026 often falls in the low tens of dollars for a form fill, but the cost per signed and qualified case is far higher because most leads never qualify. Healthy blended cost per signed case commonly lands in the low hundreds of dollars, though it varies widely by tort.

The variance is the point. A tort with light qualification (broad eligibility, minimal medical proof) can produce signed cases cheaply, while a tort requiring heavy medical verification can cost thousands per retainer. The table gives representative ranges reported across the market in 2026; treat them as directional, since costs move with competition and case criteria.

A simple worked example shows why cost per lead misleads. Suppose you pay $40 per lead and 8 percent of leads become signed, qualified cases. Your cost per signed case is $40 divided by 0.08, which is $500, before intake labor. Cut qualification rate to 4 percent and the same $40 lead now costs $1,000 per case. Small movements in screen-through rate swing unit economics more than the headline lead price does, which is why intake quality is an acquisition-cost decision, not just an operations one. Building this into a real budget is part of any sales and marketing strategy engagement we run.

What compliance rules apply to mass tort marketing?

Two regimes govern most mass tort campaigns: the ABA Model Rules of Professional Conduct 7.1 through 7.3 on lawyer advertising and solicitation, and the Telephone Consumer Protection Act (TCPA) on calls and texts. Both can apply to the same lead, and both can attach liability to the firm even when a vendor did the work. States adopt their own versions of the ABA rules, so requirements may differ by jurisdiction.

The ABA rules set the boundaries for the ad itself. TCPA sets the boundaries for how you contact the person afterward. Here is how each maps to a campaign.

On the TCPA specifically, marketing texts and autodialed calls generally require prior express written consent from that person, The FCC’s one-to-one consent rule, which would have required consent specific to a single firm, was vacated by the Eleventh Circuit in 2025, so multi-party lead consent is not currently barred on that basis. Even so, buying shared or resold consent carries real risk: courts and juries scrutinize whether consent was truly given, so treat clear, documented, firm-level consent as the safer standard and confirm current rules with counsel. Statutory exposure is often cited at roughly $500 to $1,500 per violating message, which scales fast at claimant volume. Critically, hiring a lead vendor does not transfer this risk away: a firm can face vicarious liability where it authorized the outreach, supplied its brand, or shaped the scripts. The safe posture is to verify, in writing, how consent was captured for every purchased lead before anyone calls or texts it. None of this is legal advice; confirm requirements for your jurisdiction with qualified counsel.

Should you buy leads from a vendor or build in-house?

Buy leads when you need fast scale on an active tort and lack media and intake infrastructure; build in-house when you want durable cost control, cleaner compliance ownership, and margin on volume you can predict. Many firms run a hybrid: in-house media and intake for core torts, vendors to spike volume on time-sensitive filings. The decision turns on control, cost curve, and who carries the compliance risk.

Whichever path you choose, insist on the same three things: documented consent for every contact, a defined qualification standard applied before a case counts, and cost tracked at the signed-case level. Firms that get those three right can scale a docket without the twin failure modes of overpaying for junk leads or inheriting someone else’s TCPA exposure. If you want help designing the acquisition and intake engine end to end, that is the core of our consulting services.

Frequently asked questions

What is a good cost per signed mass tort case in 2026?

A commonly cited healthy benchmark for blended cost per signed case sits in the low hundreds of dollars, often around $300 to $400 on average across torts. Light-eligibility torts can come in near $150 to $500, while cases needing heavy medical verification can run past $1,500 to $3,700 per retainer. Track cost per signed case, not cost per lead, since qualification rate drives the real number.

Which channel produces the best mass tort leads?

There is no single best channel; strong campaigns combine several. Facebook and Instagram drive volume because the exposed population is reachable and targetable there. Google Search captures high-intent claimants already looking for a specific lawsuit. Local Services Ads add Google Screened trust, and SEO builds durable lower-cost volume over time. The right mix depends on the tort, the budget, and how fast you need signed cases.

Do TCPA rules apply if I buy leads from a vendor?

Yes. Hiring a third-party lead generator does not insulate a firm from TCPA liability. A firm can face vicarious liability where it authorized the outreach, provided its brand, or shaped the calling and texting scripts. Marketing texts and autodialed calls generally require prior express written consent specific to your firm. Before contacting any purchased lead, verify in writing how consent was captured. Confirm specifics with qualified counsel.

How do mass tort firms qualify leads into signable cases?

Qualification runs as a sequence: rapid first contact within minutes, eligibility screening for product exposure and injury timing, a check against the litigation’s specific inclusion criteria, collection of medical records and proof, retainer signature, and a quality-assurance review before the case enters the docket. Most raw leads drop out at screening by design, so a low pass-through rate is expected and healthy.

Are mass tort ads considered solicitation under the ABA rules?

In many jurisdictions, yes. Mass tort advertising is frequently treated as a form of solicitation under ABA Model Rule 7.3, alongside Rule 7.1 (no false or misleading claims) and Rule 7.2 (advertising and referral records). States adopt their own versions, so the exact limits vary by jurisdiction. Have the ad creative and intake scripts reviewed against the applicable state rules before launching a campaign.

How is cost per case different from cost per lead?

Cost per lead is what you pay for a single form fill or call, often in the low tens of dollars. Cost per signed case is that lead price divided by the share of leads that become signed, qualified cases, plus intake labor. If leads cost $40 and 8 percent qualify, cost per case is $500; at 4 percent qualification it doubles to $1,000. Because qualification rate swings the result so sharply, cost per case is the number to budget against.